BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37166562)

  • 1. Association of insulin resistance with delirium and CSF biomarkers of Alzheimer's disease in elderly patients with hip fracture.
    Wang J; Shuang P; Li Z; Zhao L; Wang X; Liu P
    Aging Clin Exp Res; 2023 Jul; 35(7):1521-1529. PubMed ID: 37166562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.
    Idland AV; Wyller TB; Støen R; Eri LM; Frihagen F; Ræder J; Chaudhry FA; Hansson O; Zetterberg H; Blennow K; Bogdanovic N; Brækhus A; Watne LO
    J Alzheimers Dis; 2017; 55(1):371-379. PubMed ID: 27662296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
    Halaas NB; Zetterberg H; Idland AV; Knapskog AB; Watne LO; Blennow K
    J Alzheimers Dis; 2021; 81(2):667-677. PubMed ID: 33814433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
    Hoscheidt SM; Starks EJ; Oh JM; Zetterberg H; Blennow K; Krause RA; Gleason CE; Puglielli L; Atwood CS; Carlsson CM; Asthana S; Johnson SC; Bendlin BB
    J Alzheimers Dis; 2016 Apr; 52(4):1373-83. PubMed ID: 27079723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
    Chan CK; Sieber FE; Blennow K; Inouye SK; Kahn G; Leoutsakos JS; Marcantonio ER; Neufeld KJ; Rosenberg PB; Wang NY; Zetterberg H; Lyketsos CG; Oh ES
    Am J Geriatr Psychiatry; 2021 Dec; 29(12):1212-1221. PubMed ID: 33640268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers.
    Starks EJ; Patrick O'Grady J; Hoscheidt SM; Racine AM; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Puglielli L; Asthana S; Dowling NM; Gleason CE; Anderson RM; Davenport-Sis NJ; DeRungs LM; Sager MA; Johnson SC; Bendlin BB
    J Alzheimers Dis; 2015; 46(2):525-33. PubMed ID: 25812851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative cerebrospinal fluid biomarkers may be associated with postoperative delirium in patients undergoing knee/hip arthroplasty: the PNDABLE study.
    Lin Y; Yu N; Lin X; Deng X; Liu F; Tao H; Dong R; Wang B; Bi Y
    BMC Geriatr; 2023 May; 23(1):282. PubMed ID: 37165310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels.
    Woodfield A; Porter T; Gilani I; Noordin S; Li QX; Collins S; Martins RN; Maruff P; Masters CL; Rowe CC; Villemagne VL; Dore V; Newsholme P; Laws SM; Verdile G;
    Neurobiol Aging; 2022 Jun; 114():38-48. PubMed ID: 35381406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid β-amyloid and tau are not associated with risk of delirium: a prospective cohort study in older adults with hip fracture.
    Witlox J; Kalisvaart KJ; de Jonghe JF; Verwey NA; van Stijn MF; Houdijk AP; Traast HS; MacLullich AM; van Gool WA; Eikelenboom P
    J Am Geriatr Soc; 2011 Jul; 59(7):1260-7. PubMed ID: 21718268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia.
    Oh ES; Blennow K; Bigelow GE; Inouye SK; Marcantonio ER; Neufeld KJ; Rosenberg PB; Troncoso JC; Wang NY; Zetterberg H; Sieber FE; Lyketsos CG
    PLoS One; 2018; 13(9):e0204695. PubMed ID: 30252906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium.
    Neerland BE; Halaas NB; Idland AV; Henjum K; Blennow K; Zetterberg H; Watne LO
    J Alzheimers Dis; 2020; 77(1):183-190. PubMed ID: 32804136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
    ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology.
    Westwood S; Liu B; Baird AL; Anand S; Nevado-Holgado AJ; Newby D; Pikkarainen M; Hallikainen M; Kuusisto J; Streffer JR; Novak G; Blennow K; Andreasson U; Zetterberg H; Smith U; Laakso M; Soininen H; Lovestone S
    Alzheimers Res Ther; 2017 Apr; 9(1):31. PubMed ID: 28441961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.